Cargando…
Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models
BACKGROUND: Sulfasalazine (SSZ) is widely known as an xCT inhibitor suppressing CD44v9-expressed cancer stem-like cells (CSCs) being related to redox regulation. Cholangiocarcinoma (CCA) has a high recurrence rate and no effective chemotherapy. A recent report revealed high levels of CD44v9-positive...
Autores principales: | Thanee, Malinee, Padthaisong, Sureerat, Suksawat, Manida, Dokduang, Hasaya, Phetcharaburanin, Jutarop, Klanrit, Poramate, Titapun, Attapol, Namwat, Nisana, Wangwiwatsin, Arporn, Sa-ngiamwibool, Prakasit, Khuntikeo, Narong, Saya, Hideyuki, Loilome, Watcharin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968252/ https://www.ncbi.nlm.nih.gov/pubmed/33726850 http://dx.doi.org/10.1186/s40170-021-00249-6 |
Ejemplares similares
-
In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
por: Dokduang, Hasaya, et al.
Publicado: (2020) -
CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression
por: Thanee, Malinee, et al.
Publicado: (2021) -
A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma
por: Padthaisong, Sureerat, et al.
Publicado: (2020) -
Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
por: Tomacha, Jittima, et al.
Publicado: (2021) -
Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
por: Kittirat, Yingpinyapat, et al.
Publicado: (2022)